Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

15 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Population pharmacokinetic-pharmacodynamic analysis of givinostat.
Fiorentini F, Germani M, Del Bene F, Pellizzoni C, Cazzaniga S, Rocchetti M, Bettica P. Fiorentini F, et al. Among authors: pellizzoni c. Expert Opin Drug Metab Toxicol. 2023 Apr;19(4):229-238. doi: 10.1080/17425255.2023.2219839. Epub 2023 Jun 12. Expert Opin Drug Metab Toxicol. 2023. PMID: 37306105 Clinical Trial.
A first in man, phase I dose-escalation study of PHA-793887, an inhibitor of multiple cyclin-dependent kinases (CDK2, 1 and 4) reveals unexpected hepatotoxicity in patients with solid tumors.
Massard C, Soria JC, Anthoney DA, Proctor A, Scaburri A, Pacciarini MA, Laffranchi B, Pellizzoni C, Kroemer G, Armand JP, Balheda R, Twelves CJ. Massard C, et al. Among authors: pellizzoni c. Cell Cycle. 2011 Mar 15;10(6):963-70. doi: 10.4161/cc.10.6.15075. Epub 2011 Mar 15. Cell Cycle. 2011. PMID: 21368575 Clinical Trial.
A pharmacokinetic-pharmacodynamic model for predicting tumour growth inhibition in mice: a useful tool in oncology drug development.
Rocchetti M, Poggesi I, Germani M, Fiorentini F, Pellizzoni C, Zugnoni P, Pesenti E, Simeoni M, De Nicolao G. Rocchetti M, et al. Among authors: pellizzoni c. Basic Clin Pharmacol Toxicol. 2005 Mar;96(3):265-8. doi: 10.1111/j.1742-7843.2005.pto960325.x. Basic Clin Pharmacol Toxicol. 2005. PMID: 15733231 Free article. No abstract available.
A phase I and pharmacokinetic study of MAG-CPT, a water-soluble polymer conjugate of camptothecin.
Schoemaker NE, van Kesteren C, Rosing H, Jansen S, Swart M, Lieverst J, Fraier D, Breda M, Pellizzoni C, Spinelli R, Grazia Porro M, Beijnen JH, Schellens JH, ten Bokkel Huinink WW. Schoemaker NE, et al. Among authors: pellizzoni c. Br J Cancer. 2002 Sep 9;87(6):608-14. doi: 10.1038/sj.bjc.6600516. Br J Cancer. 2002. PMID: 12237769 Free PMC article. Clinical Trial.
Polymer-bound camptothecin: initial biodistribution and antitumour activity studies.
Caiolfa VR, Zamai M, Fiorino A, Frigerio E, Pellizzoni C, d'Argy R, Ghiglieri A, Castelli MG, Farao M, Pesenti E, Gigli M, Angelucci F, Suarato A. Caiolfa VR, et al. Among authors: pellizzoni c. J Control Release. 2000 Mar 1;65(1-2):105-19. doi: 10.1016/s0168-3659(99)00243-6. J Control Release. 2000. PMID: 10699275
Effect of rifabutin on ethambutol pharmacokinetics in healthy volunteers.
Breda M, Benedetti MS, Bani M, Pellizzoni C, Poggesi I, Brianceschi G, Rocchetti M, Dolfi L, Sassella D, Rimoldi R. Breda M, et al. Among authors: pellizzoni c. Pharmacol Res. 1999 Oct;40(4):351-6. doi: 10.1006/phrs.1999.0526. Pharmacol Res. 1999. PMID: 10527648 Clinical Trial.
Hemodynamic effects of reboxetine in healthy male volunteers.
Denolle T, Pellizzoni C, Jannuzzo MG, Poggesi I. Denolle T, et al. Among authors: pellizzoni c. Clin Pharmacol Ther. 1999 Sep;66(3):282-7. doi: 10.1016/S0009-9236(99)70036-6. Clin Pharmacol Ther. 1999. PMID: 10511064 Clinical Trial.
15 results